Vitamin e shows promise in reducing COVID-19 inflammation
Disease control
Completed
This early-phase study tested whether high doses of vitamin E (alpha-tocopherol) could reduce C-reactive protein (CRP), a marker of inflammation, in 56 adults with COVID-19. The results suggest that vitamin E supplementation may significantly lower CRP levels. The study aimed to …
Phase: EARLY_PHASE1 • Sponsor: Universidad Veracruzana • Aim: Disease control
Last updated May 17, 2026 06:50 UTC